bioplus hepatitis

April 27, 2016

The Changing Face of Liver Cancer

Hepatitis C infections get a lot of bad press when it comes to liver cancer. While it is true that hepatitis C is a significant risk […]
March 22, 2016

New Hepatitis C Combo On the Way

Another once-daily pill is on-track for approval by the U.S. Food and Drug Administration (FDA) for the treatment of hepatitis C, adding to the growing number […]
February 2, 2016

Meet Zepatier

There’s a new option in the treatment of hepatitis C, with the U.S. Food and Drug Administration (FDA) approving Merck’s Zepatier™ (elbasvir and grazoprevir) just a […]
January 20, 2016

The True Cost

Infection with the hepatitis C virus (HCV) remains a leading cause of liver cancer in the United States. Treatments now available for HCV can cure upwards […]
January 15, 2016

One Pill for All Hepatitis C Strains?

Hepatitis C comprises several different strains of the virus; in fact, there are six genotypes (numbered 1-6) which infect people. The hepatitis C medications available today […]
October 14, 2015

Timely Treatment

When one analyzes the medical records of 1.6 American adults, it turns out there’s a lot to be learned there. Researchers with the Chronic Hepatitis Cohort […]